The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 9 rounds in the feed.
Venture capitaldeerfield.comRounds from 2020-05-06 to 2026-10-30
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Setara Biosciences A clinical-stage rare disease biotech formed by Actio Biosciences alums | Series A Verified against 4 of 45 sources | $90M | 2026-10-30 | [ PART ] |
Ray Therapeutics Optogenetic therapies designed to restore functional vision for people with degenerative retinal diseases. | Series B Verified against 1 source |
| $125M |
| 2026-04-21 |
| [ PART ] |
Neomorph Neomorph develops molecular glue degraders to target and destroy disease-causing proteins. | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-04-13 | [ LEAD ] |
SHINE Technologies Shinefusion specializes in advanced nuclear technologies, including nuclear medicine, neutron testing, nuclear waste recycling, and fusion energy solutions. | Series E Verified against 2 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $240M | 2026-02-26 | [ PART ] |
MMI (Medical Microinstruments) A surgical-robotics company that makes the Symani system for microsurgery and super-microsurgery | Series C Developing, 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $110M | 2024-02-21 | [ PART ] |
Ray Therapeutics Optogenetic therapies designed to restore functional vision for people with degenerative retinal diseases. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2023-05-16 | [ PART ] |
MMI (Medical Microinstruments) A surgical-robotics company that makes the Symani system for microsurgery and super-microsurgery | Series B Verified against 1 of 5 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $75M | 2022-07-20 | [ LEAD ] |
Insilico Medicine AI-powered drug discovery and development tools to pharmaceutical companies and researchers. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $255M | 2021-06-22 | [ PART ] |
LetsGetChecked LetsGetChecked sells at-home health tests, telehealth services, and pharmacy solutions to individuals and businesses. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $71M | 2020-05-06 | [ PART ] |